Article info

Download PDFPDF
Original article
Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus

Authors

  1. Correspondence to Florine Kastelein, Department of Gastroenterology and Hepatology, Erasmus Medical Center, PO Box 2040, Rotterdam 3000 CA, The Netherlands; f.kastelein{at}erasmusmc.nl
View Full Text

Citation

Kastelein F, Biermann K, Steyerberg EW, et al
Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus

Publication history

  • Received August 22, 2012
  • Revised November 29, 2012
  • Accepted December 1, 2012
  • First published December 20, 2012.
Online issue publication 
November 07, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.